{"id":625278,"title":"Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100) - Summary - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T10:23:51.697000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents/guidance-drugs-clinical-trials-human-subjects-gui-0100.html","snippet":"Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100) - Summary File a Clinical Trial Application ( CTA ) File a Clinical Trial Application Amendment ( CTA-A ) Report Adverse Drug Reactions ( ADR s)…","rawSnapshotUrl":"/api/snapshots/raw/625278","browseUrl":"https://replay.healtharchive.ca/job-6/20260227102351/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/guidance-documents/guidance-drugs-clinical-trials-human-subjects-gui-0100.html#ha_snapshot=625278","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}